Affiliations: [a] Neuroscience Group, Research Institute Hospital 12 de Octubre, Madrid, Spain | [b] Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain
Correspondence:
[*]
Correspondence to: Eva Carro, PhD, Neuroscience Group, Research Institute Hospital 12 de Octubre, Av. de Córdoba s/n, 28041-Madrid, Spain. Tel.: +34 91 390 8765; Fax: +34 91 390 8544; E-mail: carroeva@h12o.es.
Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with senile amyloid-β (Aβ) plaques, neuronal death, and cognitive decline. Neurogenesis in the adult hippocampus, which is notably affected by progressive neurodegeneration and Aβ pathology, is implicated in learning and memory regulation. Human postmortem brains of AD patients and AβPP/PS1 double transgenic mice show increased neurodegeneration. Leptin, an adipose-derived hormone, promotes neurogenesis in the adult hippocampus, but the way in which this process occurs in the AD brain is still unknown. Thus, we sought to determine if leptin stimulated the proliferation of neuronal precursors in AβPP/PS1 mice. We estimated the number proliferating hippocampal cells after intracerebroventricular administration of a lentiviral vector encoding leptin. After 3 months of treatment with leptin we observed an increase in the number of BrdU-positive cells in the subgranular zone of the dentate gyrus, as shown by morphometric analysis. This increase resulted mainly from an increased proliferation of neuronal precursors. Additionally, leptin led to an attenuation of Aβ-induced neurodegeneration, as revealed by Fluoro-Jade staining. Our results suggest that in AβPP/PS1 mice, leptin exerts changes resembling acute neurotrophic and neuroprotective effects. These effects could serve as the basis for the design of future treatment strategies in AD.
